Tuesday, February 25, 2025 | 04:45 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Torrent Pharma leaps 10%, nears 52-wk high as Q1 net profit jumps 49% YoY

In terms of markets, while its India revenues grew marginally by 2% on a year-on-year (YoY) basis to Rs 925 crore, up from Rs 907 crore in Q1 of FY20, its US revenues fell by 1% to Rs 373 crore

According to Samir Mehta, executive chairman, Torrent Pharma, the first quarter of current fiscal witnessed challenges due to Covid-19 hampering industry growth in global markets
Premium

According to Samir Mehta, executive chairman, Torrent Pharma, the first quarter of current fiscal witnessed challenges due to Covid-19 hampering industry growth in global markets

SI Reporter New Delhi
Shares of Torrent Pharma rallied as much as 9.7 per cent to Rs 2,675.35 on the BSE on Friday after the pharmaceutical company's consolidated profit before tax jumped 44 per cent to Rs 402 crore in April-June quarter of FY21 (Q1FY21). The company's PBT in corresponding quarter last year stood at Rs 279 crore. The stock was trading close to its 52-week high level of Rs 2,679.45, touched on April 9, 2020.

Moreover, its consolidated net profit leaped 48.61 per cent to Rs 321 crore in the recently concluded quarter mainly on account of robust sales in the Indian market. The

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in